BHC - Company ID 0000885590
The table below shows Bausch Health Companies Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $2.52B | $2.68B | $2.53B | $2.26B | $2.51B | $2.40B |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A |
Bausch Health Companies Inc. reported annual revenue of $10.27B for fiscal year 2025. That is up 6.7% from $9.63B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $9.67B (FY 2016) to $10.27B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $861.00M |
| $795.00M |
| $894.00M |
| $867.00M |
| $850.00M |
| $832.00M |
| Operating income | -$950.00M | $619.00M | $444.00M | $276.00M | $318.00M | $389.00M |
| Income tax | $77.00M | $37.00M | $12.00M | $39.00M | $71.00M | $49.00M |
| Net income | -$1.42B | $179.00M | $148.00M | -$58.00M | -$85.00M | $10.00M |
| EPS (diluted) | -$3.82 | $0.48 | $0.40 | -$0.16 | -$0.23 | $0.03 |